Compare Orchid Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DR. REDDYS LAB ORCHID PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -16.6 48.9 - View Chart
P/BV x 2.6 4.7 56.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
DR. REDDYS LAB
Mar-21
ORCHID PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs2,4655,515 44.7%   
Low Rs183,028 0.6%   
Sales per share (Unadj.) Rs110.31,145.4 9.6%  
Earnings per share (Unadj.) Rs-28.5114.5 -24.9%  
Cash flow per share (Unadj.) Rs-1.9188.4 -1.0%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs159.91,053.2 15.2%  
Shares outstanding (eoy) m40.82166.30 24.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.33.7 302.0%   
Avg P/E ratio x-43.537.3 -116.5%  
P/CF ratio (eoy) x-665.622.7 -2,935.4%  
Price / Book Value ratio x7.84.1 191.4%  
Dividend payout %021.8 0.0%   
Avg Mkt Cap Rs m50,677710,289 7.1%   
No. of employees `000NANA-   
Total wages/salary Rs m67136,299 1.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,501190,475 2.4%  
Other income Rs m1522,914 5.2%   
Total revenues Rs m4,653193,389 2.4%   
Gross profit Rs m29438,699 0.8%  
Depreciation Rs m1,08912,288 8.9%   
Interest Rs m522970 53.8%   
Profit before tax Rs m-1,16528,355 -4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m09,319 0.0%   
Profit after tax Rs m-1,16519,036 -6.1%  
Gross profit margin %6.520.3 32.1%  
Effective tax rate %032.9 0.0%   
Net profit margin %-25.910.0 -259.1%  
BALANCE SHEET DATA
Current assets Rs m5,499145,503 3.8%   
Current liabilities Rs m1,42181,038 1.8%   
Net working cap to sales %90.633.8 267.7%  
Current ratio x3.91.8 215.5%  
Inventory Days Days2061 32.4%  
Debtors Days Days1,10195 1,156.9%  
Net fixed assets Rs m6,874109,979 6.3%   
Share capital Rs m408832 49.1%   
"Free" reserves Rs m6,121174,319 3.5%   
Net worth Rs m6,529175,151 3.7%   
Long term debt Rs m4,2756,299 67.9%   
Total assets Rs m12,373255,482 4.8%  
Interest coverage x-1.230.2 -4.1%   
Debt to equity ratio x0.70 1,820.6%  
Sales to assets ratio x0.40.7 48.8%   
Return on assets %-5.27.8 -66.4%  
Return on equity %-17.810.9 -164.2%  
Return on capital %-6.016.2 -36.8%  
Exports to sales %88.151.3 171.8%   
Imports to sales %37.318.1 206.2%   
Exports (fob) Rs m3,96697,699 4.1%   
Imports (cif) Rs m1,67734,420 4.9%   
Fx inflow Rs m3,96697,699 4.1%   
Fx outflow Rs m1,72934,420 5.0%   
Net fx Rs m2,23763,279 3.5%   
CASH FLOW
From Operations Rs m23635,703 0.7%  
From Investments Rs m672-22,660 -3.0%  
From Financial Activity Rs m-1,650-298 553.7%  
Net Cashflow Rs m-74212,858 -5.8%  

Share Holding

Indian Promoters % 26.7 26.7 99.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 44.0 10.3%  
FIIs % 0.8 29.3 2.7%  
ADR/GDR % 0.0 14.0 -  
Free float % 73.3 59.2 123.8%  
Shareholders   31,235 131,498 23.8%  
Pledged promoter(s) holding % 32.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   ISHITA DRUGS  GUJ.THEMIS.  BACIL PHARMA  LACTOSE INDIA  GANGA PHARMACEUTICALS  



Today's Market

Sensex Jumps 400 Points to Hit Fresh Record High; Bajaj Finance & ITC Top Gainers(09:30 am)

Asian stock markets are trading on a steady note today as traders weighed risks from China to the global recovery and the prospect of reduced Federal Reserve stimulus.

Related Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Sep 17, 2021 10:13 AM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS